Effect of bupropion on nocturnal urinary free cortisol and its association with antidepressant response.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Psychiatric Research

• Publication date

  2005-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.JPSYCHIRES.2004.01.009PMID 15589567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-HTTLPR Polymorphism of the Serotonin Transporter Gene Predicts Non-Remission in Major Depression Patients Treated With Citalopram in a 12-Weeks Follow Up Study

  2003cited by this paper
• Corticosteroid receptors in the brain: gene targeting studies.

  2002cited by this paper
• Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters.

  2002cited by this paper
• Effect of bupropion-SR on REM sleep: relationship to antidepressant response

  2002cited by this paper
• Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders.

  2001cited by this paper
• Novel approaches to the treatment of depression by modulating the hypothalamic – pituitary – adrenal axis

  2001cited by this paper
• Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy.

  2001cited by this paper
• Expression of CRHR1 and CRHR2 in Mouse Pituitary and Adrenal Gland: Implications for HPA System Regulation.

  2001cited by this paper
• Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation.

  2001cited by this paper
• Dopaminergic Role in Stimulant-Induced Wakefulness

  2001cited by this paper
• Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures.

  2001cited by this paper
• Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

  2001cited by this paper
• Major depression and the stress system: A life span perspective

  2001cited by this paper
• Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine

  2001cited by this paper
• Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization.

  2000cited by this paper
• Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated.

  2000cited by this paper
• The Corticosteroid Receptor Hypothesis of Depression

  2000cited by this paper
• Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression.

  1999cited by this paper
• Selective serotonin reuptake inhibitors and neuroendocrine function.

  1999cited by this paper
• Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression.

  1999cited by this paper
• Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load.

  1998cited by this paper
• Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis.

  1998cited by this paper
• Stressors, Stress, and Neuroendocrine Integration of the Adaptive Response: The 1997 Hans Selye Memorial Lecture

  1998cited by this paper
• Brain corticosteroid receptor balance in health and disease.

  1998cited by this paper
• Bupropion slow-release response in depression: diagnosis and biochemistry.

  1998cited by this paper
• Cerebrospinal fluid concentrations of corticotropin‐releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment

  1998cited by this paper
• DST studies in psychotic depression: a meta-analysis.

  1997cited by this paper
• Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

  1997cited by this paper
• Electroencephalographic sleep and urinary free cortisol in adolescent depression: a preliminary report of changes from episode to recovery.

  1997cited by this paper
• Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

  1996cited by this paper
• Antidepressants and hypothalamic-pituitary-adrenocortical regulation.

  1996cited by this paper
• The role of dopamine in psychotic depression.

  1995cited by this paper
• Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression.

  1995cited by this paper
• Prenatal stress prevents the desensitization of the corticosterone response to TFMPP by desmethylimipramine, but not by phenelzine, in adult male offspring.

  1995cited by this paper
• Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide.

  1994cited by this paper
• Evidence that the Acute Behavioral and Electrophysiological Effects of Bupropion (Wellbutrin®) Are Mediated by a Noradrenergic Mechanism

  1994cited by this paper
• The DST as a predictor of outcome in depression: a meta-analysis.

  1993cited by this paper
• Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.

  1993cited by this paper
• Monoamines in response and adaptation to stress

  1993cited by this paper
• Stress: From synapse to syndrome.

  1993cited by this paper
• Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy.

  1993cited by this paper
• Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression.

  1993cited by this paper
• CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse.

  1992cited by this paper
• Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.

  1991cited by this paper
• The influence of psychotropic drugs and releasing hormones on anterior pituitary hormone secretion in healthy subjects and depressed patients.

  1990cited by this paper
• Saliva and serum cortisol dynamics following intravenous dexamethasone in normal volunteers.

  1989cited by this paper
• Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.

  1987cited by this paper
• A corticosteroid/dopamine hypothesis for psychotic depression and related states.

  1985cited by this paper
• Evaluation of Bupropion Hydrochloride: The First of a New Class of Atypical Antidepressants

  1984cited by this paper
• Saliva cortisol levels following dexamethasone administration in endogenously depressed patients.

  1982cited by this paper
• Some neurochemical properties of a new antidepressant, bupropion hydrochloride (Wellbutrin™)

  1981cited by this paper
• Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.

  1980cited by this paper
• Textbook of psychopharmacology

  1975cited by this paper
• An Analysis of Variance Test for Normality (Complete Samples)

  1965cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Corrosion behavior and surface characterization of an equiatomic CoCrFeMoNi high-entropy alloy under various pH conditions

  2021cites this paper
• The Chronic Administration of Persian Herbal Formulas Psycodigest Induced The Antidepressant-Like Effect in a Chronic Unpredictable Mild Stress (CUMS) Mouse Model

  2021cites this paper
• A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures.

  2020cites this paper
• Depression and inflammation: implications for cardiovascular disease

  2020cites this paper
• Evaluation of person-level heterogeneity of treatment effects in published multiperson N-of-1 studies: systematic review and reanalysis

  2018cites this paper
• Neural and neuroendocrine predictors of pharmacological treatment response in adolescents with depression: A preliminary study

  2018cites this paper
• Manipulating dopaminergic activity with bupropion : effects on reward and emotional processing biases implicated in depression

  2016cites this paper
• Effects of Single Administration of Bupropion on Carboxypeptidase E Activity in Structures of Rat Brain

  2016cites this paper
• Bupropion response on sleep quality in patients with depression: implications for increased cardiovascular disease risk.

  2014cites this paper
• Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects.

  2014cites this paper
• Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1

  2013cites this paper
• The impact of treatment on HPA axis activity in unipolar major depression.

  2010cites this paper
• CONTRIBUTION OF HPA ACTIVITY AND ENVIRONMENTAL STRESS TO VULNERABILITY FOR SMOKING IN ADOLESCENTS

  2009cites this paper
• Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.

  2008cites this paper
• Effects of early and recent adverse experiences on adrenal response to psychosocial stress in depressed adolescents.

  2008cites this paper
• Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats.

  2007cites this paper
• Current awareness in human psychopharmacology

  2005cites this paper
• Geriatric psychiatry Advances and debates in geriatric psychopharmacology

  2005cites this paper